New Delhi, 20 Jan 2023: The expert committee, that recommends the nation’s drug regulator on approval of new drugs and clinical trials among others, has recommended to waive off the condition for conduct of Phase IV study on Tocilizumab Injection, indicated for Giant Cell A......
View Details

Related News

• J&K: 'Fake doctor' enters LD hospital's labour room, Govt appoints inquiry officer (22-09-2023)

---

• In Sriganganagar and Raisinghnagar, One family is running a dirty business of drugs (22-09-2023)

---

• Four persons involved in cheating in the name of fake pharma company arrested (22-09-2023)

---

• Two patients' health deteriorated after injection in Halat Hospital, Kanpur (22-09-2023)

---

• SEC recommends permission for phase I trial of Cadila Pharma's VZV vaccine (22-09-2023)

---

• Adding preservatives to ayurvedic medicine will change the classification of medicine (22-09-2023)

---

• 50 children fell ill after taking filariasis medicine in Purnia (21-09-2023)

---

• Two smuggling gang youths arrested, one thousand intoxicating pills recovered (21-09-2023)

---

• FSDA Meerut team raided Transport Godown in Hapur to check consignment of Phensedyl (21-09-2023)

---

• NMC gets WFME Recognition for 10 Years (21-09-2023)

---